The China market dominated the Asia Pacific Topical Scar Treatment Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,213.9 million by 2030. The Japan market is registering a CAGR of 9.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 10.8% during (2023 - 2030).
Topical scar treatments often contain ingredients that target pigmentation issues associated with scars, helping to reduce redness, hyperpigmentation, or hypopigmentation. Scar treatments may contain ingredients such as silicone, which can help improve the texture of scars by hydrating the skin and creating a smoother surface. Consumers have been increasingly seeking products with natural and organic ingredients.
The industry has seen continuous efforts to develop advanced formulations that offer improved efficacy in scar reduction. This includes innovations in delivery systems, such as gels, creams, and patches, designed to enhance the absorption of active ingredients. Consumers often prefer non-invasive or minimally invasive treatments. This trend extends to scar treatments, with topical solutions more popular than surgical or invasive procedures for certain scars.
Rising disposable income allows individuals in India to allocate funds for personal care and cosmetic products. The growing disposable income levels increase the willingness to invest in personal care and appearance in India. Higher disposable income allows consumers in India to explore and purchase various products. With higher disposable incomes, consumers in India are becoming more conscious of skincare. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.
Based on End-use, the market is segmented into Hospitals, Clinics, and Homecare. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on Product, the market is segmented into Creams, Gels, Silicon Sheets, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Sonoma Pharmaceuticals Inc.
- Molnlycke Health Care AB
- Suneva Medical, Inc.
- Perrigo Company PLC
- Cynosure, LLC
- Newmedical Technology Inc.
- Integra LifeSciences Holdings Corporation
Market Report Segmentation
By End-use- Hospitals
- Clinics
- Homecare
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
- Creams
- Gels
- Silicon Sheets
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Companies Mentioned
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Sonoma Pharmaceuticals Inc.
- Molnlycke Health Care AB
- Suneva Medical, Inc.
- Perrigo Company PLC
- Cynosure, LLC
- Newmedical Technology Inc.
- Integra LifeSciences Holdings Corporation
Methodology
LOADING...